Switching from a vitamin K antagonist to a NOAC

被引:2
|
作者
Senoo, Keitaro [1 ]
Lip, Gregory Y. H. [1 ,2 ]
机构
[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
[2] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark
来源
LANCET HAEMATOLOGY | 2015年 / 2卷 / 04期
关键词
ATRIAL-FIBRILLATION; DABIGATRAN; ANTICOAGULATION; PREVENTION; WARFARIN; STROKE; EVENTS;
D O I
10.1016/S2352-3026(15)00041-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E132 / E133
页数:2
相关论文
共 50 条
  • [41] Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial"
    Ko, Darae
    Kim, Dae Hyun
    Singer, Daniel E.
    CIRCULATION, 2024, 150 (02) : e25 - e26
  • [42] Letter by Kohsaka et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial"
    Kohsaka, Shun
    Nishimura, Shiori
    Kumamaru, Hiraku
    CIRCULATION, 2024, 150 (02) : e28 - e29
  • [43] Letter by Suwa et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial"
    Suwa, Michihiro
    Morii, Isao
    Kino, Masaya
    CIRCULATION, 2024, 150 (02) : e27 - e27
  • [44] Pros and Cons of Vitamin K Antagonists and Non-Vitamin K Antagonist Oral Anticoagulants
    Riva, Nicoletta
    Ageno, Walter
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02): : 178 - 187
  • [45] Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation
    Patti, Giuseppe
    Pecen, Ladislav
    Lucerna, Markus
    Huber, Kurt
    Rohla, Miklos
    Renda, Giulia
    Siller-Matula, Jolanta
    Ricci, Fabrizio
    Kirchhof, Paulus
    De Caterina, Raffaele
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (06): : 749 - +
  • [46] Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement
    Alaour, Bashir
    Ferrari, Enrico
    Heg, Dik
    Tueller, David
    Pilgrim, Thomas
    Muller, Olivier
    Noble, Stephane
    Jeger, Raban
    Reuthebuch, Oliver
    Toggweiler, Stefan
    Templin, Christian
    Wenaweser, Peter
    Nietlispach, Fabian
    Taramasso, Maurizio
    Huber, Christoph
    Rof, Marco
    Windecker, Stephan
    Stortecky, Stefan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (03) : 405 - 418
  • [48] Specific Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Part I (SPOCT-NOAC I)
    Hartig, Florian
    Peter, Andreas
    Spencer, Charlotte
    Ebner, Matthias
    Zurn, Christine S.
    Peveto, Theresa
    Pearman, David
    Spencer, Jeffrey
    Blumenstock, Gunnar
    Kuhn, Joachim
    Birschmann, Ingvild
    Ziemann, Ulf
    Poli, Sven
    STROKE, 2016, 47
  • [49] Specific Point-of-care Testing of Coagulation in Patients Treated with Non-vitamin K Antagonist Oral Anticoagulants Part I (SPOCT-NOAC I)
    Hartig, Florian J.
    Peter, Andreas
    Spencer, Charlotte
    Ebner, Matthias
    Meyer-Zuern, Christine
    Peveto, Theresa
    Pearman, David
    Spencer, Jeffrey
    Blumenstock, Gunnar
    Kuhn, Joachim
    Birschmann, Ingvild
    Ziemann, Ulf
    Poli, Sven
    STROKE, 2017, 48
  • [50] Non-vitamin K antagonist oral anticoagulants (NOAC): considerations on once- vs. twice-daily regimens and their potential impact on medication adherence
    Heidbuchel, Hein
    Vrijens, Bernard
    EUROPACE, 2015, 17 (08): : 1317 - 1318